These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 34234040)
1. [A Review of the History of CIDP Treatment: From Symptom Improvement to Maintenance Therapy- with a Focus on SCIg]. Kanda T; Iijima M; Sobue G Brain Nerve; 2021 Jul; 73(7):819-828. PubMed ID: 34234040 [TBL] [Abstract][Full Text] [Related]
2. Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trial. van Schaik IN; van Geloven N; Bril V; Hartung HP; Lewis RA; Sobue G; Lawo JP; Mielke O; Cornblath DR; Merkies IS; Trials; 2016 Jul; 17(1):345. PubMed ID: 27455854 [TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy, a time to start and a time to stop. Adrichem ME; Eftimov F; van Schaik IN J Peripher Nerv Syst; 2016 Sep; 21(3):121-7. PubMed ID: 27241239 [TBL] [Abstract][Full Text] [Related]
7. [Therapeutic strategy for CIDP (chronic inflammatory demyelinating polyneuropathy)]. Iijima M; Koike H; Sobue G Nihon Rinsho; 2013 May; 71(5):855-60. PubMed ID: 23777094 [TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin administration for the treatment of CIDP: IVIG or SCIG? Allen JA; Gelinas DF; Freimer M; Runken MC; Wolfe GI J Neurol Sci; 2020 Jan; 408():116497. PubMed ID: 31765922 [TBL] [Abstract][Full Text] [Related]
16. Long-term treatment with subcutaneous immunoglobulin in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a follow-up period up to 7 years. Gentile L; Mazzeo A; Russo M; Arimatea I; Vita G; Toscano A Sci Rep; 2020 May; 10(1):7910. PubMed ID: 32404895 [TBL] [Abstract][Full Text] [Related]
17. Treatment of chronic immune-mediated neuropathies: chronic inflammatory demyelinating polyradiculoneuropathy, multifocal motor neuropathy, and the Lewis-Sumner syndrome. Sederholm BH Semin Neurol; 2010 Sep; 30(4):443-56. PubMed ID: 20941678 [TBL] [Abstract][Full Text] [Related]
18. Utility of somatosensory evoked potentials in the assessment of response to IVIG in a long-lasting case of chronic immune sensory polyradiculopathy. Clerici AM; Nobile-Orazio E; Mauri M; Squellati FS; Bono GG BMC Neurol; 2017 Jul; 17(1):127. PubMed ID: 28668085 [TBL] [Abstract][Full Text] [Related]
19. Conventional and unconventional therapies in typical and atypical chronic inflammatory demyelinating polyneuropathy with different clinical course of progression. Hung SKY; Hiew FL; Viswanathan S; Puvanarajah S J Peripher Nerv Syst; 2018 Sep; 23(3):183-189. PubMed ID: 30027593 [TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulin response in treatment-naïve chronic inflammatory demyelinating polyradiculoneuropathy. Kuitwaard K; Hahn AF; Vermeulen M; Venance SL; van Doorn PA J Neurol Neurosurg Psychiatry; 2015 Dec; 86(12):1331-6. PubMed ID: 25515502 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]